Shanghai Fosun Pharmaceutical Group Co Ltd
F:08HH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Fosun Pharmaceutical Group Co Ltd
F:08HH
|
CN |
Intrinsic Value
The intrinsic value of 
Shanghai Fosun Pharmaceutical Group Co Ltd (08HH) under the Base Case is 2.457 EUR per share.
Compared with the current market price of 1.926 EUR, the stock appears
Undervalued by 22% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Shanghai Fosun Pharmaceutical Group Does
Shanghai Fosun Pharmaceutical Group is a Chinese healthcare company that makes and sells prescription drugs, specialty medicines, and some medical products. It develops and manufactures treatments for areas such as cancer, infection, central nervous system disorders, and blood-related diseases, and it also works with outside partners to bring in licensed medicines for the China market. In simple terms, it sits between drug developers and hospitals, helping turn drug research into products that doctors can use.
- Headquarters
- China CN
- Employees
- 40 603
- IPO date
- Aug 7, 1998
Revenue & Expenses Breakdown
Shanghai Fosun Pharmaceutical Group Co Ltd
Earnings Waterfall
Shanghai Fosun Pharmaceutical Group Co Ltd
The intrinsic value for Shanghai Fosun Pharmaceutical Group Co Ltd (08HH) under the Base Case is 2.457 EUR.
Compared with the current market price of 1.926 EUR, the stock appears Undervalued by 22% .